PROSPERO - Trial PHRR230616-005752
Access comprehensive clinical trial information for PHRR230616-005752 through Pure Global AI's free database. This Phase 3 trial is sponsored by AstraZeneca AB and is currently Suspended. The study focuses on Chronic Obstructive Pulmonary Disease (COPD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Philippine Health Research Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
PHRR230616-005752
Phase 3
Suspended
Trial Details
Philippine Health Research Registry • PHRR230616-005752
PROSPERO
A Phase III, Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Extension Study to Evaluate the Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease (COPD) with a History of Exacerbations
Study Focus
Interventional
Sponsor & Location
AstraZeneca AB
Philippines
Timeline & Enrollment
Phase 3
Aug 01, 2023
N/A
ICD-10 Classifications
Other chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, unspecified
Other specified chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
Chronic obstructive pulmonary disease with acute lower respiratory infection
Data Source
Philippine Health Research Registry
PHRR230616-005752
Non-Device Trial